Done sou Salè H1B

Akèy › Anplwayè › Vertex Pharmaceuticals Incorporated › Formulation Senior Research Scientist

Formulation Senior Research Scientist nan Vertex Pharmaceuticals Incorporated: Salè H-1B

5 aplikasyon kondisyon travay pou tit travay Formulation Senior Research Scientist nan Vertex Pharmaceuticals Incorporated. Salè baz medyàn ofri $116,450; mwatye mitan $116,314–$126,006.

Demann (LCA)5
Salè medyan ofri$116,450
Mwatye salè yo$116,314–$126,006
10yèm–90yèm pousantaj$115,416–$127,691

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20232$116,382
FY20252$120,412
FY20261$128,814

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$128,814–$155,000
Nivo III
Boston, MAMar 2, 2026Mar 9, 2026Certifye
$114,817–$155,341
Nivo II
Boston, MAAug 1, 2025Aug 11, 2025Certifye
$126,006–$164,973
Nivo III
Boston, MAJan 15, 2025Jul 17, 2025Certifye
$116,450–$157,550
Nivo II
Boston, MAApr 14, 2023May 22, 2023Certifye
$116,314–$155,250
Nivo III
Boston, MAMar 1, 2023Aug 22, 2023Certifye

Lòt travay nan Vertex Pharmaceuticals Incorporated

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).